At the time of writing, KKR & Co. Inc [KKR] stock is trading at $122.33, up 1.07%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The KKR shares have gain 3.88% over the last week, with a monthly amount glided 6.98%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
KKR & Co. Inc [NYSE: KKR] stock has seen the most recent analyst activity on May 14, 2025, when Morgan Stanley upgraded its rating to a Overweight but kept the price target unchanged to $150 for it. Previously, HSBC Securities upgraded its rating to Buy on April 15, 2025, and kept the price target unchanged to $119. On March 20, 2025, upgrade upgraded it’s rating to Overweight and revised its price target to $141 on the stock. HSBC Securities downgraded its rating to a Hold but stick to its price target of $173 on January 30, 2025. HSBC Securities initiated its recommendation with a Buy and recommended $148 as its price target on September 18, 2024. Wells Fargo started tracking with a Equal Weight rating for this stock on September 12, 2024, and assigned it a price target of $130. In a note dated August 27, 2024, Redburn Atlantic initiated an Buy rating and provided a target price of $153 on this stock.
For the past year, the stock price of KKR & Co. Inc fluctuated between $86.15 and $170.40. Currently, Wall Street analysts expect the stock to reach $148.33 within the next 12 months. KKR & Co. Inc [NYSE: KKR] shares were valued at $122.33 at the most recent close of the market. An investor can expect a potential return of 21.25% based on the average KKR price forecast.
Analyzing the KKR fundamentals
According to KKR & Co. Inc [NYSE:KKR], the company’s sales were 16.48B for trailing twelve months, which represents an -69.04% plunge. Gross Profit Margin for this corporation currently stands at 0.18% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at 0.35%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.09 and Total Capital is -0.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.85.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 121.30 points at the first support level, and at 120.27 for the second support level. However, for the 1st resistance point, the stock is sitting at 123.04, and for the 2nd resistance point, it is at 123.75.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 6.61, the price to book ratio is 4.36 and price to earnings (TTM) ratio is 53.03.
Transactions by insiders
Recent insider trading involved BARAKETT TIMOTHY R, Director, that happened on May 22 ’25 when 35000.0 shares were purchased. 10% Owner, KKR Genetic Disorder L.P. completed a deal on May 12 ’25 to sell 6.0 million shares. Meanwhile, Director SCULLY ROBERT W bought 13250.0 shares on May 06 ’25.
